Survival and long-term follow-up of safety and response in patients (pts) with advanced melanoma (MEL) in a phase I trial of nivolumab (anti-PD-1; BMS-936558; ONO-4538) Meeting Abstract


Authors: Sznol, M.; Kluger, H. M.; Hodi, F. S.; McDermott, D. F.; Carvajal, R. D.; Lawrence, D. P.; Topalian, S. L.; Atkins, M. B.; Powderly, J. D.; Sharfman, W. H.; Puzanov, I.; Smith, D. C.; Wigginton, J. M.; Kollia, G.; Gupta, A. K.; Sosman, J. A.
Abstract Title: Survival and long-term follow-up of safety and response in patients (pts) with advanced melanoma (MEL) in a phase I trial of nivolumab (anti-PD-1; BMS-936558; ONO-4538)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 18 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-06-20
Language: English
ACCESSION: WOS:000335564000013
PROVIDER: wos
DOI: 10.1200/jco.2013.31.18_suppl.cra9006
Notes: Meeting Abstract: CRA9006 -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL -- S -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Richard D Carvajal
    148 Carvajal